# PharmaEssentia Corporation (6446.TW) Stock Price

PharmaEssentia stock (6446.TW): the Taipei-based biopharmaceutical company developing interferon medicines; price, chart and technical indicators.

| Fact | Value |
|---|---|
| Price | NT$1,280.00 |
| Change (Nov 10 close) | −6.57% |
| Observation time | Last price · Nov 10, 2026, 05:30 (UTC) · 2026-11-10T05:30:30Z |
| 52-week range | NT$407.92 – NT$1,645.00 (daily closes to November 10, 2026, 242 observations); low on November 19, 2025, high on August 31, 2026 |
| 1Y change | +186.84% (close of November 11, 2025 to close of November 10, 2026) |
| Unit | TWD |
| Symbol | 6446.TW |
| Exchange | TAIWAN |
| Market | Stocks |

## What is PharmaEssentia Corporation (6446.TW)?

PharmaEssentia Corporation is a Taiwanese biopharmaceutical company whose registered address is in Nangang District, Taipei. According to its site, it was founded in 2003 by a group of Taiwanese-American executives and scientists, and it describes itself as a fully integrated global biopharmaceutical company delivering products for the treatment of human diseases. Its shares have traded on the Taiwan Stock Exchange since January 2024 under the code 6446.

The history page records that its ropeginterferon medicine was licensed to AOP Orphan Pharmaceutical in Austria and was developed for conditions such as polycythemia vera, essential thrombocythemia, myelofibrosis and chronic myeloid leukemia. The company page says the firm began from the question of how to unleash the full potential of interferon.

Those following PharmaEssentia usually watch clinical trial stages, licensing and distribution agreements, regulatory approval news and the Taiwan dollar exchange rate. On the Lzzo.com PharmaEssentia page, the price of the shares in Taiwan appears with its observation time, together with a price history chart and technical indicators.

Sources: pharmaessentia.com, openapi.twse.com.tw

## Similar stocks

| Name | Symbol | Last price | Change | Updated (UTC) |
|---|---|---|---|---|
| [AbbVie Inc.](https://lzzo.com/stocks/abbvie) | ABBV | $293.89 | +0.20% | Nov 10, 21:02 · 2026-11-10T21:02:16Z |
| [Merck & Co., Inc.](https://lzzo.com/stocks/merck) | MRK | $148.05 | −0.48% | Nov 10, 21:01 · 2026-11-10T21:01:51Z |
| [AstraZeneca PLC](https://lzzo.com/stocks/astrazeneca) | AZN | $186.76 | −1.39% | Nov 10, 21:00 · 2026-11-10T21:00:02Z |
| [Roche Holding AG](https://lzzo.com/stocks/roche) | ROP | CHF 401.80 | +0.17% | Nov 10, 16:30 · 2026-11-10T16:30:57Z |

## Related pages

- [All stocks](https://lzzo.com/stocks)
- [Taiwan stock market hours](https://lzzo.com/world-stock-markets/trading-hours/taiwan)
- [Compare PharmaEssentia Corporation](https://lzzo.com/compare)
- [Market heatmap](https://lzzo.com/stock-market-heatmap)
- [Data and calculation methods](https://lzzo.com/methodology)

---
Canonical HTML page: https://lzzo.com/stocks/pharmaessentia · Not investment advice.